Stryker Corporation vs Tripadvisor Inc Common Stock — how do they compare? Stryker Corporation trades at $277.33 (market cap $106.24B), while Tripadvisor Inc Common Stock trades at $8.68 (market cap $1.01B). The key difference: Stryker Corporation is far larger — about 105.2× Tripadvisor Inc Common Stock's market cap, and Stryker Corporation pays a 1.27% dividend while Tripadvisor Inc Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Stryker Corporation for 21 Days and Tripadvisor Inc Common Stock for 57 Days on average.
| SYK | TRIP | |
|---|---|---|
Market Cap | $106.24B | $1.01B |
Volume | 2,982,001 | 3,004,748 |
Sector | Health | Consumer Cyclical |
52-Week High | $388.35 | $16.72 |
52-Week Low | $269.75 | $8.04 |
Typical Hold Time | 21 Days | 57 Days |
Enterprise Value | $117.70B | $1.06B |
Dividend Yield | 1.27% | — |
Signals from Pluang's Aura AI — not financial advice
Stryker (SYK) trades at $276.97, up 0.57% with mixed technical signals showing bearish moving averages but neutral oscillators. The company maintains strong profitability with 64.98% gross margins and 14.43% net income margin, though recent Q1 2026 earnings missed expectations. Analyst consensus remains strongly bullish with 71% buy ratings and $368.11 price target, representing 33% upside potential. Recent news highlights ongoing legal investigations regarding manufacturing issues that caused an 8.8% stock drop in September 2026.
SYK presents a compelling investment case with robust fundamentals and strong analyst support, though near-term headwinds from legal scrutiny and manufacturing challenges create uncertainty. The stock's current valuation at 28.7 P/E appears reasonable given growth prospects, but investors should monitor Q3 2026 earnings results on October 29 for confirmation of business recovery from recent setbacks.
TripAdvisor (TRIP) trades at $8.96, up 3.82% with a bullish technical signal despite recent earnings misses. The stock shows mixed fundamentals with strong gross margins (92.11%) but thin net income (0.27%), while valuation appears reasonable with P/S of 0.57. Recent news highlights institutional buying interest but also concerns about AI competition eroding the core business model.
The outlook remains cautious with Wall Street maintaining a hold-heavy consensus (62.5%) despite a $13.58 price target suggesting 52% upside. Key risks include persistent earnings underperformance, competitive pressure from AI travel tools, and declining cash flow trends. The investment case hinges on Viator's performance and successful execution amid travel industry disruption.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →TripAdvisor is the world's leading travel metasearch company. The website offers 1 billion reviews and information on about 8 million accommodations, restaurants, experiences, airlines, and cruises. In 2021, 74% of revenue came from the company's core segment, which includes hotel revenue generated through advertising on its metasearch platform. Viator, its experiences brand, was 20% of sales in 2021, and TheFork, its dining brand, represented 9% of revenue (about 3% of sales were intersegment, which are eliminated from consolidated revenue).
Read more on TRIP →